Voya Investment Management LLC Cti Biopharma Corp Transaction History

Voya Investment Management LLC

  • $79.9 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$5.36 - $7.43 $17,087 - $23,686
3,188 Added 9.01%
38,574 $225,000
Q2 2022

Aug 15, 2022
BUY
$3.55 - $6.27 $125,620 - $221,870
35,386 New
35,386 $211,000
Q2 2019

Aug 14, 2019
SELL
$0.8 - $1.03 $14,973 - $19,278
-18,717 Closed
0 $0
Q2 2018

Aug 14, 2018
BUY
$3.81 - $5.26 $71,311 - $98,451
18,717 New
18,717 $93,000

About CTI BIOPHARMA CORP

CTIC Quotes by TradingView
  • Ticker CTIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 114,385,000
  • Market Cap $1.04B
  • Description
  • CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...
More about CTIC
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email